MDM2 antagonist-loaded targeted micelles in combination with doxorubicin: effective synergism against human glioblastoma via p53 re-activation

dc.date.accessioned	2020-10-21T06:45:22Z
dc.date.available	2020-10-21T06:45:22Z
dc.date.issued	2019
dc.date.issued	2019/01/19
dc.identifier.citation	Tan Y, Liu J, Bilir C.J Drug Target. 2019 Jun-Jul;27(5-6):624-633. doi: 10.1080/1061186X.2019.1570518. Epub 2019 Jan 25.
dc.identifier.uri	http://doi.org/10.1080/1061186X.2019.1570518
dc.identifier.uri	https://hdl.handle.net/20.500.12619/71578
dc.description	PMID = 30656973
dc.relation.isversionof	10.1080/1061186X.2019.1570518
dc.rights	info:eu-repo/semantics/closedAccess
dc.title	MDM2 antagonist-loaded targeted micelles in combination with doxorubicin: effective synergism against human glioblastoma via p53 re-activation
dc.type	article
dc.relation.journal	J Drug Target
dc.identifier.doi	10.1080/1061186X.2019.1570518
dc.contributor.author	Sarisozen C
dc.contributor.author	Tan Y
dc.contributor.author	Liu J
dc.contributor.author	Bilir C
dc.contributor.author	Shen L
dc.contributor.author	Filipczak N
dc.contributor.author	Porter TM
dc.contributor.author	Torchilin VP.
dc.relation.publicationcategory	Makale - Uluslararası Hakemli Dergi